195990 — ABPro Bio Co Share Price
- KR₩91bn
- KR₩92bn
- KR₩32bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.85 | ||
Price to Tang. Book | 1 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.89 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -30.73% | ||
Return on Equity | -13.57% | ||
Operating Margin | -116.71% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 35,797.23 | 32,913.99 | 22,112.07 | 25,375.41 | 31,663.09 | n/a | n/a | -0.17% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.
Directors
- Seong Jin Jung CCE (42)
- Seong Min Lee CCE (52)
- Jong Su Kim OTH (58)
- Jun Du Lee OTH (52)
- Yin Cheol Lee OTH (49)
- Hwi Geun Park OTH (56)
- Jae Gyu Lee DRC (43)
- Jae Min Hwang NID (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 12th, 2004
- Public Since
- April 13th, 2015
- No. of Shareholders
- 51,844
- No. of Employees
- 73
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 284,687,906

- Address
- 139, Techno jungang-daero, Yuga-myeon, DAEGU, 43022
- Web
- http://www.abprobio.co.kr/
- Phone
- +82 535828036
- Auditors
- JUNGIN Accounting Corp
Upcoming Events for 195990
Similar to 195990
Alux Co (Seoul)
Korea Exchange - KOSDAQ
APro Co
Korea Exchange - KOSDAQ
ASIA TECHNOLOGY Co
Korea Exchange - KOSDAQ
A-Tech Solution Co
Korea Exchange - KOSDAQ
Atum Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:02 UTC, shares in ABPro Bio Co are trading at KR₩321. This share price information is delayed by 15 minutes.
Shares in ABPro Bio Co last closed at KR₩321 and the price had moved by -38.34% over the past 365 days. In terms of relative price strength the ABPro Bio Co share price has underperformed the FTSE Developed Asia Pacific Index by -37.64% over the past year.
There is no consensus recommendation for this security.
Find out moreABPro Bio Co does not currently pay a dividend.
ABPro Bio Co does not currently pay a dividend.
ABPro Bio Co does not currently pay a dividend.
To buy shares in ABPro Bio Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩321, shares in ABPro Bio Co had a market capitalisation of KR₩91bn.
Here are the trading details for ABPro Bio Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 195990
Based on an overall assessment of its quality, value and momentum ABPro Bio Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ABPro Bio Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -35.29%.
As of the last closing price of KR₩321, shares in ABPro Bio Co were trading -25.22% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ABPro Bio Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩321.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ABPro Bio Co's management team is headed by:
- Seong Jin Jung - CCE
- Seong Min Lee - CCE
- Jong Su Kim - OTH
- Jun Du Lee - OTH
- Yin Cheol Lee - OTH
- Hwi Geun Park - OTH
- Jae Gyu Lee - DRC
- Jae Min Hwang - NID